190 related articles for article (PubMed ID: 3263446)
1. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
[TBL] [Abstract][Full Text] [Related]
2. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.
Parsonnet J; Gillis ZA
J Infect Dis; 1988 Nov; 158(5):1026-33. PubMed ID: 3263447
[TBL] [Abstract][Full Text] [Related]
3. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
Hackett SP; Stevens DL
J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
[TBL] [Abstract][Full Text] [Related]
4. Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.
Kum WW; Laupland KB; See RH; Chow AW
J Clin Microbiol; 1993 Oct; 31(10):2654-60. PubMed ID: 8253961
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
See RH; Kum WW; Chang AH; Goh SH; Chow AW
Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
[TBL] [Abstract][Full Text] [Related]
6. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of experimental toxic shock syndrome: the role of interleukin-2 in the induction of hypotension and release of cytokines.
Tokman MG; Carey KD; Quimby FW
Shock; 1995 Feb; 3(2):145-51. PubMed ID: 7749941
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
10. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.
Jupin C; Anderson S; Damais C; Alouf JE; Parant M
J Exp Med; 1988 Mar; 167(3):752-61. PubMed ID: 3127526
[TBL] [Abstract][Full Text] [Related]
11. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1.
de Azavedo JC; Drumm A; Jupin C; Parant M; Alouf JE; Arbuthnott JP
FEMS Microbiol Immunol; 1988 Jul; 1(2):69-74. PubMed ID: 3273461
[TBL] [Abstract][Full Text] [Related]
13. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
14. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
[TBL] [Abstract][Full Text] [Related]
15. Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.
Sperber K; Silverstein L; Brusco C; Yoon C; Mullin GE; Mayer L
Clin Diagn Lab Immunol; 1995 Jul; 2(4):473-7. PubMed ID: 7583927
[TBL] [Abstract][Full Text] [Related]
16. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
Bonventre PF; Heeg H; Edwards CK; Cullen CM
Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
[TBL] [Abstract][Full Text] [Related]
17. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
Krakauer T; Stiles BG
Clin Diagn Lab Immunol; 1999 Jul; 6(4):594-8. PubMed ID: 10391869
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]